Abstract
A pilot study of immunization with interleukin-2 secreting allogeneic HLA-A2 matched renal cell carcinoma cells in patients with advanced renal cell carcinoma.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have